The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction
We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,...
Saved in:
Published in | QJM : An International Journal of Medicine Vol. 91; no. 10; pp. 667 - 676 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
01.10.1998
|
Subjects | |
Online Access | Get full text |
ISSN | 1460-2393 1460-2725 1460-2393 |
DOI | 10.1093/qjmed/91.10.667 |
Cover
Loading…
Abstract | We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres. |
---|---|
AbstractList | We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres. We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres.We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other cardiovascular endpoints. The study is prospective, based in three centres in the south, east and north of France and in Northern Ireland. A total of 10,592 men aged 50-59 years were recruited from 1991 to 1993, and examined for evidence of IHD at baseline. Subjects are followed annually by questionnaire. Clinical information is validated from hospital and GP records. Demographic characteristics were similar in all four centres. Body mass index was highest in Strasbourg (mean 27.4 kg/m2 vs. 26.3 kg/m2 in Toulouse and Belfast), but total cholesterol, triglyceride and fibrinogen were highest in Belfast. In Belfast, 6.1% reported having had a coronary angiogram, compared to 3.0% in Toulouse. Conversely, 13.8% in Toulouse reported taking lipid-lowering drugs vs. 1.6% in Belfast. As predicted, a history of myocardial infarction (MI) was highest in Belfast (6.1%) and lowest in Toulouse (1.2%). Some 7.1% of Belfast men reported a medical diagnosis of angina vs. 1.5% in Toulouse. Subjects showing evidence of pre-existing IHD will be studied prospectively but treated in the analysis as an additional variable. These results provide a measure of reassurance that these cohorts are representative of the communities from which they are drawn and provide a reliable baseline for prospective evaluation and cross-sectional comparisons. The levels of the classical risk factors found in this study, particularly when examined in combination, as multiple logistic functions based on previous British studies, are very similar between centres and cannot explain the large differences in the incidence of IHD which exist. Additional risk factors may help explain, at least in part, the major differences in incidence of IHD between these study centres. |
Author | Yarnell, J. |
Author_xml | – sequence: 1 givenname: J. surname: Yarnell fullname: Yarnell, J. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/10024924$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kV9vFCEUxYmpsX_02Tdzn3zbXWBmZwbfTLPVTdraaH2eMHCxVBamwFb3e_qBZLZt0pj4BBx-53Iv55gc-OCRkLeMzhkV1eLudoN6IVg5zZumfUGOWN3QGa9EdfBsf0iOU7qllNZt3b0ih4xSXgteH5E_1zcIV1_XFytIeat3H0A5mZJV0kG06ScYqXKICXQAHzLg79FJ6yEXW8J7jNKZ4DRoawxG9AoTlOu9NRhQIQYv4w5uUMZcqIQyIQyYfyF6OIuyOEB6DZchlprRwzqiK8IcrmJII6ps7xFWo9W4scGFH_vWvk29Tg9c7IKSUduirb2RseDBvyYvjXQJ3zyuJ-T72er69PPs_Mun9enH85liHWtnquNc6GHgSKXsBsNNWzExcMEYo42osdOyo6ZdKkFZhd3AB1N13VDgquZCVifk_UPdMYa7Labcb2xS6Er_GLapbwRr6VLwAr57BLdDCawfo92UX-mfcijA4gFQZegU0TxD-inpfp90L9gklKSLY_mPQ9ksp-lzlNb91_cXoEezKw |
CitedBy_id | crossref_primary_10_1016_j_ijcard_2005_04_024 crossref_primary_10_1038_sj_ejhg_5201277 crossref_primary_10_1016_j_respe_2012_05_009 crossref_primary_10_1017_S0007114507842826 crossref_primary_10_1186_1471_2350_11_119 crossref_primary_10_3389_fcvm_2017_00073 crossref_primary_10_1093_ije_dyh267 crossref_primary_10_1373_clinchem_2010_152751 crossref_primary_10_1016_S0002_8703_99_70268_1 crossref_primary_10_1093_cid_cis489 crossref_primary_10_1002_sim_4130 crossref_primary_10_1093_eurheartj_ehp254 crossref_primary_10_1111_j_1538_7836_2004_00981_x crossref_primary_10_1016_S0021_9150_03_00280_6 crossref_primary_10_1007_s12160_016_9784_x crossref_primary_10_1016_S0007_9960_05_80496_1 crossref_primary_10_1161_01_CIR_0000084542_64687_97 crossref_primary_10_1161_01_ATV_0000022850_59845_E0 crossref_primary_10_1016_j_appet_2007_03_223 crossref_primary_10_1007_s11812_014_0067_9 crossref_primary_10_1161_JAHA_117_006389 crossref_primary_10_1038_ijo_2009_204 crossref_primary_10_1016_S0049_3848_01_00245_6 crossref_primary_10_1016_j_jad_2013_07_010 crossref_primary_10_1161_01_ATV_0000079512_66448_1D crossref_primary_10_1161_01_CIR_0000016345_58696_4F crossref_primary_10_1007_s00394_020_02455_2 crossref_primary_10_1007_s10654_013_9808_9 crossref_primary_10_1016_j_atherosclerosis_2005_06_017 crossref_primary_10_1186_1471_2334_5_61 crossref_primary_10_1093_ije_30_5_1057 crossref_primary_10_1093_qjmed_hcr128 crossref_primary_10_1016_j_atherosclerosis_2004_10_029 crossref_primary_10_1111_j_1538_7836_2005_01486_x crossref_primary_10_1016_j_diabres_2016_07_010 crossref_primary_10_1038_jhh_2009_34 crossref_primary_10_1111_jcpe_12450 crossref_primary_10_1111_jcpe_12691 crossref_primary_10_1161_CIRCULATIONAHA_109_901413 crossref_primary_10_1093_europace_euw401 crossref_primary_10_1093_jnci_djw127 crossref_primary_10_1097_01_hjr_0000230097_81202_9f crossref_primary_10_1111_j_1600_051X_2012_01923_x crossref_primary_10_1097_00004872_200402000_00028 crossref_primary_10_1136_jech_2013_203053 crossref_primary_10_1016_j_atherosclerosis_2009_03_025 crossref_primary_10_1038_ajh_2011_94 crossref_primary_10_1111_j_1600_051X_2006_01030_x crossref_primary_10_1017_S0007114520001518 crossref_primary_10_1097_HJH_0b013e3282fd991f crossref_primary_10_1371_journal_pone_0273333 crossref_primary_10_1093_ije_dyq271 crossref_primary_10_1542_peds_2008_1118 crossref_primary_10_1002_ana_22669 crossref_primary_10_1016_S0021_9150_02_00026_6 crossref_primary_10_1016_S0167_5273_00_00283_7 crossref_primary_10_1016_j_ijcard_2014_09_102 crossref_primary_10_1016_S0007_9960_05_80464_X crossref_primary_10_1111_j_1600_051X_2009_01468_x crossref_primary_10_1097_PSY_0000000000000289 crossref_primary_10_1016_S0899_9007_00_00335_X crossref_primary_10_1007_s11845_020_02498_8 crossref_primary_10_1016_j_atherosclerosis_2006_05_014 crossref_primary_10_1016_j_ypmed_2011_04_006 crossref_primary_10_1161_01_CIR_0000164203_54111_AE crossref_primary_10_1016_j_annepidem_2007_01_017 crossref_primary_10_1016_j_ypmed_2013_04_003 crossref_primary_10_1161_01_CIR_0000099509_76044_A2 crossref_primary_10_1016_j_atherosclerosis_2011_05_034 crossref_primary_10_1161_01_CIR_0000120705_55512_EC crossref_primary_10_1038_sj_ijo_0801635 crossref_primary_10_1111_jcpe_13377 crossref_primary_10_1016_S0021_9150_02_00309_X crossref_primary_10_1161_01_ATV_0000248096_62495_73 crossref_primary_10_1177_1741826711417341 crossref_primary_10_1016_j_jad_2007_03_012 crossref_primary_10_1111_j_1540_8159_2000_tb00860_x crossref_primary_10_1097_HJR_0b013e32830fe479 crossref_primary_10_1038_ejcn_2012_70 crossref_primary_10_1111_jcpe_13819 crossref_primary_10_1016_S1262_3636_07_70306_3 crossref_primary_10_1016_j_jdent_2019_103265 crossref_primary_10_1016_j_ijcard_2015_10_118 crossref_primary_10_1016_j_atherosclerosis_2009_07_018 crossref_primary_10_1093_ije_dyg038 crossref_primary_10_1016_j_atherosclerosis_2007_08_019 crossref_primary_10_17116_profmed201518324_30 crossref_primary_10_1097_00008469_200008000_00002 crossref_primary_10_1097_00004872_200303000_00017 crossref_primary_10_1097_01_hjr_0000136416_24769_42 crossref_primary_10_1046_j_1538_7836_2003_00398_x crossref_primary_10_1111_jcpe_13510 crossref_primary_10_1016_j_jada_2005_09_004 crossref_primary_10_1111_j_1600_051X_2007_01075_x crossref_primary_10_1079_BJN20041286 crossref_primary_10_1111_jcpe_13076 crossref_primary_10_1016_j_amjcard_2008_09_092 crossref_primary_10_1111_j_1600_051X_2008_01288_x crossref_primary_10_1097_CEJ_0b013e328359cba7 crossref_primary_10_1093_ije_31_6_1227 crossref_primary_10_1161_ATVBAHA_112_300109 crossref_primary_10_1371_journal_pone_0285117 crossref_primary_10_1155_2009_543746 crossref_primary_10_1186_s12916_020_01776_7 crossref_primary_10_1016_S0021_9150_99_00484_0 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/qjmed/91.10.667 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2393 |
EndPage | 676 |
ExternalDocumentID | 10024924 10_1093_qjmed_91_10_667 |
Genre | Multicenter Study Journal Article Comparative Study |
GeographicLocations | France Northern Ireland |
GeographicLocations_xml | – name: Northern Ireland – name: France |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .XZ .ZR 08G 0R~ 123 18M 1TH 29P 2WC 354 3O- 4.4 482 48X 53G 5RE 5VS 5WA 5WD 70D 8F7 AABZA AACZT AAJKP AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAYEP AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQNK ABVGC ABWST ABXVV ABZBJ ACGFS ACUFI ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AEMQT AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFXAL AFYAG AGINJ AGKEF AGORE AGQPQ AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ASPBG ATGXG AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CAG CDBKE CITATION COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z MHKGH ML0 N9A NGC NOMLY NOYVH NU- NVLIB O0~ O9- OAUYM OAWHX OB2 OCZFY ODMLO OHH OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TR2 VVN W8F WH7 WOQ X7H X7M YAYTL YKOAZ YOC YXANX ZKX ~91 08P 6.Y AAJQQ AAPGJ AAQQT AAWDT ABNGD ABQTQ ABSMQ ACFRR ACPQN ACUTJ ACZBC ADJQC ADRIX AEHUL AEKPW AFFQV AFSHK AFXEN AGKRT AGMDO APJGH AQDSO AQKUS ATTQO BZKNY CGR CUY CVF ECM EIF EIHJH H13 M49 MBLQV NPM NTWIH O~Y RHF TMA ZXP 7X8 |
ID | FETCH-LOGICAL-c1817-c8229dbb2e0aa8bf2f7319b291110694e8da80f75c9013e8b2bf388baa83429a3 |
ISSN | 1460-2393 1460-2725 |
IngestDate | Fri Sep 05 00:10:57 EDT 2025 Wed Feb 19 02:33:09 EST 2025 Thu Apr 24 23:12:51 EDT 2025 Tue Aug 05 12:02:32 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1817-c8229dbb2e0aa8bf2f7319b291110694e8da80f75c9013e8b2bf388baa83429a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://academic.oup.com/qjmed/article-pdf/91/10/667/9909871/910667.pdf |
PMID | 10024924 |
PQID | 69170592 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_69170592 pubmed_primary_10024924 crossref_primary_10_1093_qjmed_91_10_667 crossref_citationtrail_10_1093_qjmed_91_10_667 |
PublicationCentury | 1900 |
PublicationDate | 1998-10-1 1998-Oct 19981001 |
PublicationDateYYYYMMDD | 1998-10-01 |
PublicationDate_xml | – month: 10 year: 1998 text: 1998-10-1 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | QJM : An International Journal of Medicine |
PublicationTitleAlternate | QJM |
PublicationYear | 1998 |
References | 11339214 - QJM. 2001 Mar;94(3):173-4 |
References_xml | – reference: 11339214 - QJM. 2001 Mar;94(3):173-4 |
SSID | ssj0004748 |
Score | 1.5314909 |
Snippet | We are studying the contribution of risk and genetic factors, and their interaction, to the development of ischaemic heart disease (IHD) and other... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 667 |
SubjectTerms | Anthropometry Blood Pressure Coronary Disease - blood Coronary Disease - epidemiology Coronary Disease - physiopathology Follow-Up Studies France - epidemiology Humans Life Style Lipids - blood Male Mass Screening - methods Middle Aged Northern Ireland - epidemiology Prospective Studies Risk Factors Socioeconomic Factors |
Title | The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction |
URI | https://www.ncbi.nlm.nih.gov/pubmed/10024924 https://www.proquest.com/docview/69170592 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Jj9MwFICtMkiIC2KfDts7cECq0kniNIm5IdQyM5oOWyuVU2RnOaCSMKU9wH_g3_GDeM9LmhmoWC5R5dpJ5PfFfrbfwtjTHHVqKXiEmps_8qLALzwZBcLDpUFFU4oKlLa2OIuP5tHJYrTo9b53rJY2azXMv_3Wr-R_pIplKFfykv0HybY3xQL8jfLFK0oYr38t4zfvjqdjEyWWVvc5acO647XRuEunUzSDullTPP-ltJaNOCXSflTVLIs2TYoxz-rYm68a7a5Laa_X7jCnte3SSTnM8YM-_qGkasfkHFMXQ_JAcF6cg_E2Da1-tfcukvX0K06lq8IE_Kjwm2sxsfry25PpYOfepVWkp5fMAz7IVWu7Y-wHzbaG9vNzBnJuJI5i3wsT4xXthmoRdJH0OwNvbJJ6_DIhmGBZ5x8_0dbxRARYMrR1LwbfPnudTeanp9lsvJhdYVfDJNGn_q8WW4uhKNHJ2No3c5GiBD_UDzhsb39RydmxctEazOwmu2F7DF4Yjm6xXlnfZtdc791hPxAn0DiBxuk5tDABEQEWJigaQJjAwgQoeOjABB2YAP_WTZsKHEygYQILE1iYwMAEyA44mMDBBB2Y4BJMoGGiB2xhgi1Md9l8Mp69PPJs0g8vR2Uz8XLKQFAoFZa-lKmqwirBWUKFNCmTk3aZFjL1q2SUC9rBT1WoKp6mCitz1K0kv8f26qYu9xnEKarbXMiYlzwaJYmMU5VW2Fc8rATP8z4bOilluY2IT4lZlpmxzOCZFmsmAipAsfbZs7bBZxMMZnfVJ07sGQ7YdAon67LZfMliQRGsRNhn9w0NnVvp-J3RwR_bPmDXt9_MQ7a3Xm3KR6gcr9VjjexPFWrEjg |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+PRIME+study%3A+classical+risk+factors+do+not+explain+the+severalfold+differences+in+risk+of+coronary+heart+disease+between+France+and+Northern+Ireland.+Prospective+Epidemiological+Study+of+Myocardial+Infarction&rft.jtitle=QJM+%3A+An+International+Journal+of+Medicine&rft.au=Yarnell%2C+J+W&rft.date=1998-10-01&rft.issn=1460-2725&rft.volume=91&rft.issue=10&rft.spage=667&rft_id=info:doi/10.1093%2Fqjmed%2F91.10.667&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2393&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2393&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2393&client=summon |